| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1116826 | B | Inhibition of Trypanosoma brucei MAC2 | Trypanosoma brucei | 19 | ALA1155398 | single protein format | Scientific Literature | |
| 2. | ALA1116827 | F | Antiparasitic activity against Trypanosoma brucei brucei bloodstream form | Trypanosoma brucei brucei | 19 | ALA1155398 | organism-based format | Scientific Literature | |
| 3. | ALA1116828 | F | Antiparasitic activity against Trypanosoma cruzi amastigotes | Trypanosoma cruzi | 19 | ALA1155398 | organism-based format | Scientific Literature | |
| 4. | ALA1116829 | F | Antiparasitic activity against Leishmania infantum amastigotes | Leishmania infantum | 19 | ALA1155398 | organism-based format | Scientific Literature | |
| 5. | ALA1116830 | F | Antiparasitic activity against Plasmodium falciparum ring stage and schizont | Plasmodium falciparum | 19 | ALA1155398 | organism-based format | Scientific Literature | |
| 6. | ALA1116831 | A | Cytotoxicity against human MRC5 cells | Homo sapiens | 19 | ALA1155398 | cell-based format | Scientific Literature | |
| 7. | ALA3832785 | F | AntiTrypanosoma cruzi activity IC50 (uM) | Trypanosoma cruzi | 65 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 8. | ALA3832786 | F | AntiTrypanosoma brucei activity T. b. brucei IC50 (uM) | Trypanosoma brucei | 64 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 9. | ALA3832787 | F | AntiTrypanosoma brucei activity T. b. rhodesiense IC50 (uM) | Trypanosoma brucei | 62 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 10. | ALA3832789 | F | AntiLeishmania activity L. infantum (macrophages) IC50 (uM) | Leishmania infantum | 65 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 11. | ALA3832790 | F | AntiLeishmania activity L. donovani (axenic) IC50 (uM) | Leishmania donovani | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 12. | ALA3832791 | F | AntiLeishmania activity L. donovani (macrophages) IC50 (uM) | Leishmania donovani | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 13. | ALA3832792 | F | AntiLeishmania activity Toxicity on infected PMM (uM) | Leishmania | 14 | ALA3832761 | organism-based format | MMV Pathogen Box | |
| 14. | ALA3832841 | F | L6 CC50 (uM) Cytotoxicity | 14 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 15. | ALA3832842 | F | MRC5 CC50 (uM) Cytotoxicity | 77 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 16. | ALA3832843 | F | PMM CC50 (uM) Cytotoxicity | 65 | ALA3832761 | cell-based format | MMV Pathogen Box | ||
| 17. | ALA3987222 | B | Compound was evaluated for the inhibition of human FECH at 10uM | Homo sapiens | 400 | ALA3987221 | single protein format | MMV Pathogen Box | |
| 18. | ALA3987223 | B | Compound was evaluated for the inhibition of human HMBS at 100uM | Homo sapiens | 400 | ALA3987221 | assay format | MMV Pathogen Box | |
| 19. | ALA4296184 | F | Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) | Staphylococcus aureus | 4,588 | ALA4296181 | organism-based format | CO-ADD antimicrobial screening data | |
| 20. | ALA4296185 | F | Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600) | Escherichia coli | 4,585 | ALA4296181 | organism-based format | CO-ADD antimicrobial screening data |
The page will load shortly, Thanks for your patience!